VTVT vs WY · rev $36.8M vs P/E 43, rev $3.59B
vTv Therapeutics Inc (VTVT) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
vTv Therapeutics Inc (VTVT) is a biotechnology company listed on NASDAQ.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported VTVT revenue for 2026-06-30 was $36.8M. Net income was $11.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. VTVT currently screens at market cap $133.9M.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
VTVT currently screens at market cap $133.9M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the VTVT and WY stock pages for the full models.
Not investment advice.